Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephanie Nevison
Stephanie Nevison
University of Toronto
Medicine
Dihydropyrimidine dehydrogenase
DPYD
Adverse effect
Internal medicine
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events
2021
Clinical and Translational Science
Theodore J. Wigle
Brandi L. Povitz
Samantha Medwid
Wendy A. Teft
Robin M. Legan
John Lenehan
Stephanie Nevison
Veera Durga Sravanthi Panuganty
Denise Keller
Jaymie Mailloux
Victoria Siebring
Sisira Sarma
Yun-Hee Choi
Stephen Welch
Eric Winquist
Ute I. Schwarz
Richard B. Kim
Show All
Source
Cite
Save
Citations (2)
Anti-CV2-Associated Paraneoplastic Hemichorea Secondary to Diffuse Large B-cell Lymphoma
2019
Canadian Journal of Neurological Sciences
Stephanie Nevison
Philippe Rizek
Show All
Source
Cite
Save
Citations (1)
Prospective cohort study of the impact of hospital-wide dihydropyrimidine dehydrogenase (DPYD) genotype testing for fluoropyrimidine-based chemotherapy on adverse events and hospital costs.
2019
Journal of Clinical Oncology
Theodore J. Wigle
Brandi Povitz
Wendy A. Teft
Robin Legan
John Lenehan
Markus Gulilat
Stephanie Nevison
Justin Kritzinger
Veera Punaganty
Denise Keller
Suhair AlShanteer
Robin Francis
Victoria Siebring
Sisira Sarma
Yun-Hee Choi
Stephen Welch
Eric Winquist
Ute I. Schwarz
Richard B. Kim
Show All
Source
Cite
Save
Citations (1)
1